Patent · US Active

Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells

US11690919B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 17, 2018
Grant dateJul 4, 2023
Priority date
Expiry dateAug 18, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Endolysosomal targeting conjugates that are engineered to deliver cargo molecules such as cytotoxic drugs or imaging labels with improved efficiency to late endosomes and/or lysosomes in target cells such as tumor cells are described. The endolysosomal targeting conjugate includes a targeting component and a cargo component. The targeting component is configured to bind to a cell surface molecule of a target cell and the cargo component includes a cargo molecule. The targeting component and the cargo component may be fused by a covalent bond or associated by a non-covalent bond. The targeting component may bind to the cell surface molecule or the cargo component with higher affinity in the extracellular space than in an endolysosomal compartment of the target cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.